Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome

Background: Lennox-Gastaut syndrome (LGS) is a severe form of childhood-onset epilepsy associated with serious injuries due to frequent and severe seizures. Of the antiepileptic drugs (AEDs) approved for LGS, clobazam is a more recent market entrant, having been approved in October 2011. Recent AED...

Descripción completa

Detalles Bibliográficos
Autores principales: François, Clément, Stern, John M., Ogbonnaya, Augustina, Lokhandwala, Tasneem, Landsman-Blumberg, Pamela, Duhig, Amy, Shen, Vivienne, Tan, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2017
Materias:
Transferred Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508372/
https://www.ncbi.nlm.nih.gov/pubmed/28740620
http://dx.doi.org/10.1080/20016689.2017.1318691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508372/
https://www.ncbi.nlm.nih.gov/pubmed/28740620
http://dx.doi.org/10.1080/20016689.2017.1318691

Ejemplares similares